Theravance to Present at Investor Conferences in June 2012
May 22, 2012 16:05 ET
|
Theravance, Inc.
SOUTH SAN FRANCISCO, Calif., May 22, 2012 (GLOBE NEWSWIRE) -- Theravance, Inc. (Nasdaq:THRX) announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at...
GlaxoSmithKline Completes Transaction to Increase Its Ownership in Theravance
May 16, 2012 09:17 ET
|
Theravance, Inc.
LONDON and SOUTH SAN FRANCISCO, Calif., May 16, 2012 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc ("GSK") (LSE:GSK) and Theravance, Inc. ("Theravance") (Nasdaq:THRX) announced today that following approval...
Theravance to Webcast 2012 Annual Meeting of Stockholders on May 15, 2012
May 08, 2012 16:05 ET
|
Theravance, Inc.
SOUTH SAN FRANCISCO, Calif., May 8, 2012 (GLOBE NEWSWIRE) -- Theravance, Inc. (Nasdaq:THRX) announced today that it will webcast its 2012 Annual Meeting of Stockholders at 1:00 p.m. Pacific Daylight...
Theravance Reports First Quarter 2012 Financial Results
April 26, 2012 16:05 ET
|
Theravance, Inc.
SOUTH SAN FRANCISCO, Calif., April 26, 2012 (GLOBE NEWSWIRE) -- Theravance, Inc. (Nasdaq:THRX) reported today its financial results for the quarter ended March 31, 2012. Revenue for the first quarter...
Theravance to Present at Investor Conferences in May 2012
April 24, 2012 16:05 ET
|
Theravance, Inc.
SOUTH SAN FRANCISCO, Calif., April 24, 2012 (GLOBE NEWSWIRE) -- Theravance, Inc. (Nasdaq:THRX) announced today that Theravance management is scheduled to present at the following investor conferences...
Theravance to Report First Quarter 2012 Financial Results on April 26, 2012
April 12, 2012 16:05 ET
|
Theravance, Inc.
SOUTH SAN FRANCISCO, Calif., April 12, 2012 (GLOBE NEWSWIRE) -- Theravance, Inc. (Nasdaq:THRX) announced today that it will release financial results for the period ended March 31, 2012 after market...
GlaxoSmithKline to Increase Its Ownership in Theravance
April 02, 2012 07:33 ET
|
Theravance, Inc.
LONDON and SOUTH SAN FRANCISCO, Calif., April 2, 2012 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (GSK) and Theravance, Inc. (Nasdaq:THRX) announced today that they have entered into a stock purchase...
Theravance to Present at the 11th Annual Needham Healthcare Conference
March 27, 2012 16:05 ET
|
Theravance, Inc.
SOUTH SAN FRANCISCO, Calif., March 27, 2012 (GLOBE NEWSWIRE) -- Theravance, Inc. (Nasdaq:THRX) announced today that Mathai Mammen, M.D., Ph.D., Theravance's Senior Vice President, Research and Early...
GSK and Theravance Announce Completion of the Relovair(TM)* Registrational Programme and Topline Results From Relovair(TM) vs. Advair(R) Phase III Studies in COPD
March 23, 2012 08:00 ET
|
Theravance, Inc.
LONDON and SOUTH SAN FRANCISCO, Calif., March 23, 2012 (GLOBE NEWSWIRE) -- GlaxoSmithKline (GSK) and Theravance, Inc. (Nasdaq:THRX) today announced that the registrational programme for...
Theravance to Present at the Cowen and Company 32nd Annual Health Care Conference
February 22, 2012 16:05 ET
|
Theravance, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2012 (GLOBE NEWSWIRE) -- Theravance, Inc. (Nasdaq:THRX) announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at...